Search for more clinical trials
the Quality of Life Assessment of Advanced Non-small Cell Lung Cancer in China
Conditions
Non-small Cell Lung Cancer. - Clinical Stage IIIb or IV
Conditions: official terms
Carcinoma, Non-Small-Cell Lung - Lung Neoplasms
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Case-Only, Time Perspective: Prospective
Overall Status
Recruiting
Summary
The goal of this study is assess the quality of life of advanced non-small cell lung cancer (NSCLC) patients who are undergoing first-line chemotherapy, analyze the current status and tendency of quality of life (QOL). The method is to use the Functional Assessment of Cancer Therapy-Lung (FACT-L) scales, assess the quality of life before the chemotherapy, after 1st cycle of chemotherapy and after 2nd cycle. After 3 time-points, investigators analyze all the subscales and constructs of FACT-L. The assumption is the quality of life will be better after 2 cycle of chemotherapy.
Detailed Description
1. Lung cancer is the most deadly cancer in the world, 85% lung cancer are non-small cell lung cancer (NSCLC). The quality of life of NSCLC patients become more and more important, because of most NSCLC is incurable.
2. The recruitment will take place in 20 center all over the country and 500 patients will enrolled.
2. The recruitment will take place in 20 center all over the country and 500 patients will enrolled.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: 75 Years
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:
- age: >18 and <75 years old
- pathological or cytological diagnosis confirmed advanced non-small cell lung cancer
- Eastern Cooperative Oncology Group Performance Status: 0-2
- have never receive any kind of anti-cancer chemotherapy
- agree to regularly assessment of quality of life
- sign the informed consent form
Exclusion Criteria:
- Currently attending any antitumor drug clinical trials
- Pregnancy or breast-feeding women
- Currently receiving anti-tumor chemotherapy, or received any antitumor chemotherapy previously.
- not suitable to participate in this test
- age: >18 and <75 years old
- pathological or cytological diagnosis confirmed advanced non-small cell lung cancer
- Eastern Cooperative Oncology Group Performance Status: 0-2
- have never receive any kind of anti-cancer chemotherapy
- agree to regularly assessment of quality of life
- sign the informed consent form
Exclusion Criteria:
- Currently attending any antitumor drug clinical trials
- Pregnancy or breast-feeding women
- Currently receiving anti-tumor chemotherapy, or received any antitumor chemotherapy previously.
- not suitable to participate in this test
Location
Sun Yat-Sen University Cancer Center
GuangZhou, Guangdong, China
Status: Recruiting
Contact: YuXiang Ma - 8602087343786 - mayx@sysucc.org.cn
Start Date
November 2012
Completion Date
June 2015
Sponsors
Sun Yat-sen University
Source
Sun Yat-sen University
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page